Fundraising FoxSoutheast Minnesota Capital Fund — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Vyriadvyriad.comin𝕏Oct 2019
Vyriad is a clinical-stage biotechnology company developing oncolytic virus-based therapies for cancer treatment.
BiotechHealthtechMedical DevicesRochester, US
Stephen J. Russell, MD, PhD(Executive Officer, Director, Promoter)Kah-Whye Peng, PhD(Executive Officer)Stephen J. Russell(Executive Chairman and Chief Scientific Officer, Co-founder)Kah-Whye Peng(Co-Founder and Chief Technical Officer)inLuke Russell(President)inAlice S. Bexon(Chief Medical Officer)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.